Q1 2024 Earnings Call May 5, 2024 Lexicon Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at ...

Recorded a net loss of $48.4 million, or $0.20 per share, closely aligning closely with the estimated loss of $51.02 million ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) just reported results for the first quarter of 2024.Lexicon Pharmaceuticals reported ...

Yigal Nochomovitz, an analyst from Citi, maintained the Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report). The associated ...

Lexicon Pharmaceuticals (NASDAQ: LXRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.17 per share a year ago.

Fintel reports that on April 30, 2024, Leerink Partners initiated coverage of Lexicon Pharmaceuticals (NasdaqGS:LXRX) with a ...

By Chris Wack Lexicon Pharmaceuticals said that Lonnel Coats has provided notice of his retirement as chief executive officer and member of the board ...

The The Woodlands, Texas-based company said it had a loss of 20 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

LITTLE ROCK (KATV) — Lexicon, Inc. hosted the American Welding Society at Mills University Studies High School on Friday to inspire and inform students of all the opportunities in the welding ...

Lexicon Institute of Media & Animation (Lexicon IMA) is revolutionizing media education in Pune by offering students ...

Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic PainTHE WOODLANDS, ...

THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Thursday reported a loss of $48.4 million in its first quarter. The The Woodlands, Texas-based ...